Deceptive Advertising! Claims Novo in GLP-1 Lawsuit Fallout
Two pharmaceutical giants are in court over GLP-1 advertising. This tangle could redefine how GLP-1s are marketed and...
Extra expenses call for smart tweaks. This intro covers simple ways to adjust your budget to accommodate additional costs.
12,871 articlesTwo pharmaceutical giants are in court over GLP-1 advertising. This tangle could redefine how GLP-1s are marketed and...
A leading energy markets strategist warns that natural gas supply and price volatility could become a critical cost d...
Pan American Silver released its quarterly results after the bell, delivering a blend of record revenue and strong ea...
A Phase 3 breakthrough unleashed a dramatic move in Cogent Biosciences. A large fund followed with a sizable stake, s...
Is there a true housing shortage in the United States, or is the story driven by location, price, and policy? This ar...
Ford's China negotiations could redefine its growth trajectory. This article explains the real reason investors shoul...
A major fund trims a big stake in a tech name, sparking questions about risk, sector exposure, and portfolio resilien...
Investors have watched robinhood stock been volatile as the company transitions from breakneck growth to a steadier, ...
Markets pivot as traders wake to the reality of potentially punitive tariffs, sending stocks lower and gold higher in...
A private AI company launches a $0.85-per-share pre-IPO round, inviting accredited investors to join pre-IPO before t...
Investors grapple with AI-driven disruption as markets remain volatile in early 2026. Experts outline disciplined ste...
KXI powers higher on risk-off flows, yet currency swings across Nestlé, Coca-Cola, Walmart and other holdings threate...